Dogwood Therapeutics, Inc. (ticker: DWTX) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of DWTX's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. DWTX reported no tagged revenue in revenue and -$34.26M for the period ending 2025-12-31, with operating cash flow of -$15.62M. Cash and equivalents stood at $6.52M (down 56.1% year-over-year). Total assets of $90.17M exceed total liabilities of $15.27M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
DWTX Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Dogwood Therapeutics, Inc. (DWTX) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.